Australian clinicians now have PBS access to combination bortezomib/lenalidomide/dexamethasone (VRd) for upfront treatment of multiple myeloma. In this podcast, Professor Hang Quach discusses the key recommendations of the Medical and Scientific Advisory Group (MSAG) update on upfront VRd, and offers insights from her own experiences of its use in the clinic. Professor Hang Quach Hang is ...
VRd for initial treatment of multiple myeloma – Prof Hang Quach discusses the new MSAG recommendations
22 Jan 2021